DAIICHI SANKYO COMPANY, LIMITED
Patent Applications and Registrations
Patent applications and USPTO patent grants for DAIICHI SANKYO COMPANY, LIMITED.The latest application filed is for "klk5 inhibitory peptide".
Company Profile
200.200.200
Trademarks
- DAIICHI SANKYO COMPANY, LIMITED - Tokyo JP
- Daiichi Sankyo Company, Limited - Chuo-ku, Tokyo JP
- Daiichi Sankyo Company, Limited - Toyko JP
- DAIICHI SANKYO CO., LTD. - Tokyo JP
- DAIICHI SANKYO COMPANY, LIMITED - Chuo-ku JP
- Daiichi Sankyo Company, Limited - Shinagawa-ku JP
- Daiichi Sankyo Company, Limited - Vancouver CA
- Daiichi Sankyo Company, Limited - Saitama JP
- Daiichi Sankyo Company, Limited - Bunkyo-ku JP
- Daiichi Sankyo Company, Limited - Setagaya-ku JP
- Daiichi Sankyo Company, Limited - Yamato-shi JP
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Klk5 Inhibitory Peptide App 20220306725 - Nishimiya; Daisuke ; et al. | 2022-09-29 |
| Anti-CDH6 antibody and method of producing an anti-CDH6 antibody-drug conjugate Grant 11,446,386 - Saito , et al. September 20, 2 | 2022-09-20 |
| Anti-ALK2 antibody Grant 11,447,554 - Katagiri , et al. September 20, 2 | 2022-09-20 |
| Aminoalkyl compound Grant 11,440,896 - Suzuki September 13, 2 | 2022-09-13 |
| Ophthalmic aqueous composition Grant 11,439,652 - Endo , et al. September 13, 2 | 2022-09-13 |
| Therapeutic Agent For Cancer Having Resistance To Anti-ccr4 Antibody App 20220280492 - FUJITANI; Sumiaki | 2022-09-08 |
| Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugate Grant 11,434,289 - Iida , et al. September 6, 2 | 2022-09-06 |
| Antibody Recognizing Extracellular Region Of Alk2/acvr1 App 20220267453 - KATAGIRI; Takenobu ; et al. | 2022-08-25 |
| Method For Producing A Spirooxindole Derivative App 20220259216 - YAMAUCHI; Motoshi ; et al. | 2022-08-18 |
| Griseofulvin compound and pharmaceutical use thereof Grant 11,407,746 - Saito , et al. August 9, 2 | 2022-08-09 |
| Novel Method For Producing Antibody-drug Conjugate App 20220226497 - NISHI; Yoshio ; et al. | 2022-07-21 |
| Method for selecting individuals to be administered immune checkpoint inhibitor Grant 11,371,995 - Yonesaka , et al. June 28, 2 | 2022-06-28 |
| Pyrrolopyrazole Derivative App 20220185815 - NAMIKI; Hidenori ; et al. | 2022-06-16 |
| Anti-her2 Antibody-pyrrolobenzodiazepine Derivative Conjugate App 20220177601 - HARADA; Naoya ; et al. | 2022-06-09 |
| Combination Of Antibody-pyrrolobenzodiazepine Derivative Conjugate And Parp Inhibitor App 20220168438 - HARADA; Naoya ; et al. | 2022-06-02 |
| Antibody-pyrrolobenzodiazepine Deprivative Conjugate App 20220168440 - TODA; Narihiro ; et al. | 2022-06-02 |
| Anti-her3 Antibody-drug Conjugate App 20220172420 - HETTMANN; Thore ; et al. | 2022-06-02 |
| Urea Derivative App 20220144765 - Soneda; Tsuyoshi ; et al. | 2022-05-12 |
| Combination Of Antibody-drug Conjugate And Immune Checkpoint Inhibitor App 20220143009 - IWATA; Tomomi ; et al. | 2022-05-12 |
| Method for producing antibody-drug conjugate Grant 11,318,212 - Nishi , et al. May 3, 2 | 2022-05-03 |
| Peptide library and use thereof Grant 11,319,345 - Nishimiya , et al. May 3, 2 | 2022-05-03 |
| Combination therapy of Axl inhibitor and EGFR tyrosine kinase inhibitor Grant 11,318,124 - Jimbo May 3, 2 | 2022-05-03 |
| Antibody-pyrrolobenzodiazepine Derivative Conjugate App 20220125943 - TODA; Narihiro ; et al. | 2022-04-28 |
| Anti-ALK2 antibody Grant 11,312,776 - Katagiri , et al. April 26, 2 | 2022-04-26 |
| Pharmaceutical composition used for treatment of HTLV-1-associated myelopathy Grant 11,311,524 - Yamano , et al. April 26, 2 | 2022-04-26 |
| Tablet having uniquely identifiable shape, tablet verification device and program Grant 11,308,607 - Ito , et al. April 19, 2 | 2022-04-19 |
| Anti-HER3 antibody-drug conjugate Grant 11,298,359 - Hettmann , et al. April 12, 2 | 2022-04-12 |
| Anti-cd147 Antibody App 20220106393 - FUKUCHI; Keisuke ; et al. | 2022-04-07 |
| Peptides Inhibiting Klk1, Klk4, Or Klk4 And Klk8 App 20220106384 - Nishimiya; Daisuke ; et al. | 2022-04-07 |
| Dispiropyrrolidine Derivatives App 20220106324 - SUGIMOTO; Yuuichi ; et al. | 2022-04-07 |
| KLK5 inhibitory peptide Grant 11,292,828 - Nishimiya , et al. April 5, 2 | 2022-04-05 |
| Methods For Purifying Antibodies Comprising Of A Process By Using Activated Carbon Materials App 20220098235 - MASUDA; Yumiko ; et al. | 2022-03-31 |
| Combination of antibody-drug conjugate and immune checkpoint inhibitor Grant 11,273,155 - Iwata , et al. March 15, 2 | 2022-03-15 |
| EP300/CREBBP inhibitor Grant 11,274,100 - Naito , et al. March 15, 2 | 2022-03-15 |
| Dosage Regimen Of Mdm2 Inhibitor For Treating Cancers App 20220071975 - TSE; Ngai-chiu Archie ; et al. | 2022-03-10 |
| Treatment Of Her3-mutated Cancer By Administration Of Anti-her3 Antibody-drug Conjugate App 20220072144 - KOYAMA; Kumiko ; et al. | 2022-03-10 |
| Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate Grant 11,261,261 - Naito , et al. March 1, 2 | 2022-03-01 |
| Anti-GPR20 antibody Grant 11,261,249 - Iida , et al. March 1, 2 | 2022-03-01 |
| Combination Of Antibody-drug Conjugate And Kinase Inhibitor App 20220040324 - ISHII; Chiaki ; et al. | 2022-02-10 |
| Anti-alk2 Antibody App 20220041738 - KATAGIRI; Takenobu ; et al. | 2022-02-10 |
| Pexidartinib Risk Evaluation And Mitigation Strategy (rems) App 20220036993 - SHUSTER; Dale Edward ; et al. | 2022-02-03 |
| Immunity-inducing Agent Comprising Antigen Peptide-adjuvant Nucleotide Conjugate And Pharmaceutical Composition Comprising Same App 20220031839 - Mochizuki; Shinichi ; et al. | 2022-02-03 |
| Methods For Administering Pexidartinib App 20220034871 - SHUSTER; Dale Edward ; et al. | 2022-02-03 |
| Cycloalkane-1,3-diamine derivative Grant 11,236,106 - Yoshikawa , et al. February 1, 2 | 2022-02-01 |
| Combination Of Antibody-drug Conjugate With Parp Inhibitor App 20220023436 - OGITANI; Yusuke ; et al. | 2022-01-27 |
| Therapeutic drug for Alport's syndrome Grant 11,230,709 - Iijima , et al. January 25, 2 | 2022-01-25 |
| Anti-cdh6 Antibody-pyrrolobenzodiazepine Derivative Conjugate App 20220016257 - SAITO; Atsuko ; et al. | 2022-01-20 |
| Anti-garp Antibody App 20220010026 - SATOH; Kazuki ; et al. | 2022-01-13 |
| Novel Cyclic Dinucleotide Derivative And Antibody-drug Conjugate Thereof App 20220008549 - TSUDA; Toshifumi ; et al. | 2022-01-13 |
| Pyridone Derivative Having Tetrahydropyranylmethyl Group App 20220002277 - HAGINOYA; Noriyasu ; et al. | 2022-01-06 |
| Method Of Improving Blood Kinetics Of Peptide App 20220002385 - Nishimiya; Daisuke ; et al. | 2022-01-06 |
| Pyridone derivatives having tetrahydropyranylmethyl groups Grant 11,208,403 - Haginoya , et al. December 28, 2 | 2021-12-28 |
| Endo-beta-N-acetylglucosaminidase Grant 11,208,442 - Ito , et al. December 28, 2 | 2021-12-28 |
| Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8 Grant 11,208,467 - Nishimiya , et al. December 28, 2 | 2021-12-28 |
| Ezh1/2 Dual Inhibitor-containing Pharmaceutical Composition To Be Used As A Combination Drug App 20210393601 - HONMA; Daisuke | 2021-12-23 |
| Method For Selectively Manufacturing Antibody-drug Conjugate App 20210386865 - NOGUCHI; Shigeru ; et al. | 2021-12-16 |
| (Anti-HER2 antibody)-drug conjugate Grant 11,185,594 - Naito , et al. November 30, 2 | 2021-11-30 |
| Biaryl Derivative App 20210355087 - Tsuji; Takashi ; et al. | 2021-11-18 |
| Method for selectively manufacturing antibody-drug conjugate Grant 11,173,213 - Noguchi , et al. November 16, 2 | 2021-11-16 |
| Peptide For Treating Retinitis Pigmentosa App 20210347836 - Inoue; Tatsuya | 2021-11-11 |
| Klk5 Inhibitory Peptide App 20210340221 - Nishimiya; Daisuke ; et al. | 2021-11-04 |
| Sensitivity Marker For Antibody-drug Conjugate App 20210340628 - OKAJIMA; Daisuke ; et al. | 2021-11-04 |
| Stabilizer-containing Solid Drug Formulation App 20210330592 - ARAI; Hiroaki ; et al. | 2021-10-28 |
| Anti-human Tlr7 Antibody App 20210332149 - Miyake; Kensuke ; et al. | 2021-10-28 |
| Method For Producing A Spirooxindole Derivative App 20210323970 - YAMAUCHI; Motoshi ; et al. | 2021-10-21 |
| Thrombospondin 1-binding peptide Grant 11,149,066 - Yamaguchi , et al. October 19, 2 | 2021-10-19 |
| PROMOTER of Hspa8 GENE App 20210317498 - Masuda; Kenji ; et al. | 2021-10-14 |
| Griseofulvin Compound App 20210292292 - Saito; Keiji ; et al. | 2021-09-23 |
| Combination Of Antibody-drug Conjugate And Tubulin Inhibitor App 20210290775 - OGITANI; Yusuke ; et al. | 2021-09-23 |
| Treatment Of Metastatic Brain Tumor By Administration Of Antibody-drug Conjugate App 20210290777 - SUGIHARA; Kiyoshi ; et al. | 2021-09-23 |
| Effective Method For Manufacturing Antibody-drug Conjugate App 20210283269 - YAMAGUCHI; Tatsuya ; et al. | 2021-09-16 |
| Compositions Including Cd3 Antigen Binding Fragments And Uses Thereof App 20210277118 - SPRETER VON KREUDENSTEIN; Thomas | 2021-09-09 |
| Granules Containing Diamine Derivative App 20210267954 - SCHMID; Wolfgang ; et al. | 2021-09-02 |
| Cycloalkane-1,3-diamine Derivative App 20210269454 - Yoshikawa; Kenji ; et al. | 2021-09-02 |
| Anti-human TLR7 antibody Grant 11,091,560 - Miyake , et al. August 17, 2 | 2021-08-17 |
| Anti-trop2 Antibody-drug Conjugate App 20210238303 - AGATSUMA; Toshinori ; et al. | 2021-08-05 |
| Azetidine Derivative, And Prodrug Thereof App 20210238136 - Maruoka; Hiroshi ; et al. | 2021-08-05 |
| Anti-CDH6 antibody and anti-CDH6 antibody-drug conjugate Grant 11,077,202 - Saito , et al. August 3, 2 | 2021-08-03 |
| Dosage regimen of MDM2 inhibitor for treating cancers Grant 11,058,673 - Tse , et al. July 13, 2 | 2021-07-13 |
| DNA element having the activity of enhancing foreign gene expression Grant 11,060,108 - Nishimiya , et al. July 13, 2 | 2021-07-13 |
| Urea Derivative App 20210206716 - Soneda; Tsuyoshi ; et al. | 2021-07-08 |
| Treatment Of Her2-mutated Cancer By Administering Anti-her2 Antibody-drug Conjugate App 20210205466 - FUJISAKI; Yoshihiko ; et al. | 2021-07-08 |
| Myocardial Dysfunction Therapeutic Agent App 20210207136 - MATSUO; Masafumi ; et al. | 2021-07-08 |
| Sulfonamide compounds Grant 11,046,710 - Miyazaki , et al. June 29, 2 | 2021-06-29 |
| Anti-garp antibody Grant 11,046,780 - Satoh , et al. June 29, 2 | 2021-06-29 |
| Anti-muc1 Antibody-drug Conjugate App 20210187118 - GELLERT; Johanna ; et al. | 2021-06-24 |
| Method for Producing Diarylpyridine Derivatives App 20210188823 - Aki; Yuichi ; et al. | 2021-06-24 |
| Pyrimidine derivative Grant 11,034,659 - Takeda , et al. June 15, 2 | 2021-06-15 |
| Tablet Grant 11,033,502 - Sekine June 15, 2 | 2021-06-15 |
| Protein Recognizing Drug Moiety Of Antibody-drug Conjugate App 20210169852 - SOMA; Masako ; et al. | 2021-06-10 |
| Ep300/crebbp Inhibitor App 20210171520 - Naito; Hiroyuki ; et al. | 2021-06-10 |
| Method for Producing 3,6-Disubstituted-Imidazo[1,2-B]Pyridazine Derivative App 20210171532 - Koike; Ryoji ; et al. | 2021-06-10 |
| Method for producing 3, 6-disubstituted imidazo[1, 2-b]pyridazine derivative Grant 11,028,091 - Koike , et al. June 8, 2 | 2021-06-08 |
| Pyridine Compound App 20210163464 - Inagaki; Hiroaki ; et al. | 2021-06-03 |
| ANTI-SIRPalpha ANTIBODY App 20210155707 - MATOZAKI; Takashi ; et al. | 2021-05-27 |
| Sulfonamide compounds Grant 11,014,939 - Miyazaki , et al. May 25, 2 | 2021-05-25 |
| Complex containing oligonucleotide having immunopotentiating activity and use thereof Grant 11,015,202 - Ishii , et al. May 25, 2 | 2021-05-25 |
| Anti-TROP2 antibody-drug conjugate Grant 11,008,398 - Agatsuma , et al. May 18, 2 | 2021-05-18 |
| HANP-Fc-containing molecular conjugate Grant 11,008,392 - Iwamoto , et al. May 18, 2 | 2021-05-18 |
| Endos mutant enzyme Grant 11,001,819 - Kawaguchi , et al. May 11, 2 | 2021-05-11 |
| Antibody-drug Conjugate Preparation And Lyophilization For Same App 20210128741 - KAMII; Tetsuo ; et al. | 2021-05-06 |
| Combination of human anti-FGFR4 antibody and Sorafenib Grant 10,995,143 - Abraham , et al. May 4, 2 | 2021-05-04 |
| Griseofulvin compound Grant 10,975,052 - Saito , et al. April 13, 2 | 2021-04-13 |
| Antibody-drug conjugate Grant 10,973,924 - Masuda , et al. April 13, 2 | 2021-04-13 |
| Urea derivative Grant 10,968,169 - Soneda , et al. April 6, 2 | 2021-04-06 |
| Formulations of a compound modulating kinases Grant 10,961,240 - Ibrahim , et al. March 30, 2 | 2021-03-30 |
| Oligodendrocyte-specific Promoter, Mirna Specific To Plp1 Gene,vector Including Said Promoter And/or Mirna, And Pharmaceutical Composition Including Said Vector App 20210087560 - Inoue; Ken ; et al. | 2021-03-25 |
| 1,3-benzodioxole derivative Grant 10,954,219 - Kanno , et al. March 23, 2 | 2021-03-23 |
| Glyco-modified atrial natriuretic peptide Grant 10,947,289 - Iwamoto , et al. March 16, 2 | 2021-03-16 |
| Formulations of a compound modulating kinases Grant 10,941,142 - Ibrahim , et al. March 9, 2 | 2021-03-09 |
| Dihydroindolizinone Derivative App 20210053965 - Kiho; Toshihiro ; et al. | 2021-02-25 |
| Amide derivative Grant 10,925,848 - Soneda , et al. February 23, 2 | 2021-02-23 |
| Method of constructing masses of myocardial cells and use of the myocardial cell mass Grant 10,918,671 - Hattori , et al. February 16, 2 | 2021-02-16 |
| Glyco-modified Atrial Natriuretic Peptide App 20210040170 - IWAMOTO; Mitsuhiro ; et al. | 2021-02-11 |
| Anti-human Tlr7 Antibody App 20210040225 - Miyake; Kensuke ; et al. | 2021-02-11 |
| Aminoalkyl Compound App 20210040057 - Suzuki; Keisuke | 2021-02-11 |
| Klk5 Inhibitory Peptide App 20210032313 - Nishimiya; Daisuke ; et al. | 2021-02-04 |
| Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugate Grant 10,906,974 - Iida , et al. February 2, 2 | 2021-02-02 |
| Therapeutic Agent For Lcat Deficiency App 20210024520 - Sugidachi; Atsuhiro ; et al. | 2021-01-28 |
| Combination Of Anti-fgfr4-antibody And Bile Acid Sequestrant App 20210023211 - Abraham; Reimar ; et al. | 2021-01-28 |
| Pharmaceutical Composition For Treating Or Preventing Heterotopic Ossification App 20210009709 - KATAGIRI; Takenobu ; et al. | 2021-01-14 |
| Therapeutic Agent For Inflammatory Bowel Disease App 20210008069 - TOYOSHIMA; Yuki | 2021-01-14 |
| Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereof Grant 10,881,734 - Yoshimura , et al. January 5, 2 | 2021-01-05 |
| Therapeutic Agent For Glycogen Storage Disease Type Ia App 20200407394 - KOIZUMI; Makoto ; et al. | 2020-12-31 |
| Anti-cdh6 Antibody And Anti-cdh6 Antibody-drug Conjugate App 20200390900 - SAITO; Atsuko ; et al. | 2020-12-17 |
| Oligonucleotides, Manufacturing Method For Same, And Target Rna Site-specific Editing Method App 20200392496 - FUKUDA; Masatora | 2020-12-17 |
| Method Of Treating Cancer Comprising Administration Of Anti-her2 Antibody-drug Conjugate App 20200385486 - NAITO; Hiroyuki ; et al. | 2020-12-10 |
| Novel Method For Producing Antibody-drug Conjugate App 20200384121 - NISHI; Yoshio ; et al. | 2020-12-10 |
| Method For Producing Antibody-drug Conjugate App 20200385422 - YAMAGUCHI; Tatsuya ; et al. | 2020-12-10 |
| Peptide For Treating Age-related Macular Degeneration App 20200377573 - Nishimiya; Daisuke ; et al. | 2020-12-03 |
| Pyridine compound Grant 10,851,092 - Inagaki , et al. December 1, 2 | 2020-12-01 |
| Method for producing a spirooxindole derivative Grant 10,851,111 - Yamauchi , et al. December 1, 2 | 2020-12-01 |
| Anti-Orai1 antibody Grant 10,851,162 - Komai , et al. December 1, 2 | 2020-12-01 |
| Anti-cd147 Antibody App 20200362033 - FUKUCHI; Keisuke ; et al. | 2020-11-19 |
| Anti-gpr20 Antibody And Anti-gpr20 Antibody-drug Conjugate App 20200362032 - IIDA; Kenji ; et al. | 2020-11-19 |
| Ophthalmic Aqueous Composition App 20200352964 - ENDO; Yoko ; et al. | 2020-11-12 |
| Combination Therapy Of Axl Inhibitor And Egfr Tyrosine Kinase Inhibitor App 20200345709 - JIMBO; Takeshi | 2020-11-05 |
| Compound Having Cyclic Structure App 20200347030 - Taniguchi; Toru ; et al. | 2020-11-05 |
| Crystals of [2-(1-methyl-1H-pyrazol-4-yl)-6(morpholin-4-yl)-9H-purin-8-yl][4-(morphol- in-4-yl)piperidin-1-yl]methanone and pharmaceutically acceptable salt thereof Grant 10,822,336 - Ueda , et al. November 3, 2 | 2020-11-03 |
| Drug For Retinal Degenerative Disease Associated With Photoreceptor Degeneration App 20200330415 - Tsuji; Naoki ; et al. | 2020-10-22 |
| Sustained-release pharmaceutical composition for treatment and prevention of eye disease Grant 10,808,006 - Kasuya , et al. October 20, 2 | 2020-10-20 |
| Sulfonamide derivative having coumarin skeleton Grant 10,774,087 - Ota , et al. Sept | 2020-09-15 |
| Antibody-drug Conjugate App 20200282073 - MASUDA; Takeshi ; et al. | 2020-09-10 |
| Method for predicting responsiveness to cancer treatment using p300-inhibiting compound Grant 10,768,179 - Kohno , et al. Sep | 2020-09-08 |
| Combination of anti-FGFR4-antibody and bile acid sequestrant Grant 10,765,738 - Abraham , et al. Sep | 2020-09-08 |
| Ophthalmic aqueous composition Grant 10,758,554 - Endo , et al. Sep | 2020-09-01 |
| N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives Grant 10,752,647 - Khera , et al. A | 2020-08-25 |
| Antibody-pyrrolobenzodiazepine Derivative Conjugate App 20200261594 - TODA; Narihiro ; et al. | 2020-08-20 |
| Composition For Cytotoxic T Cell Depletion App 20200262917 - Mukasa; Ryuta ; et al. | 2020-08-20 |
| Antisense Oligonucleotide And Composition For Prevention Or Treatment Of Glycogen Storage Disease Type Ia App 20200246369A1 - | 2020-08-06 |
| Cationic lipid Grant 10,731,159 - Koizumi , et al. | 2020-08-04 |
| Antibody-drug conjugate produced by binding through linker having hydrophilic structure Grant 10,729,782 - Naito , et al. | 2020-08-04 |
| Synthesis of a compound that modulates kinases Grant 10,730,876 - Ibrahim , et al. | 2020-08-04 |
| Griseofulvin Compound App 20200239425 - Saito; Keiji ; et al. | 2020-07-30 |
| Antibody targeting osteoclast-related protein siglec-15 Grant 10,723,800 - Hiruma , et al. | 2020-07-28 |
| Active Mmp9-binding Peptide App 20200231654 - Yano; Hidenori ; et al. | 2020-07-23 |
| Method for treating cancer by combined use Grant 10,716,790 - Seki | 2020-07-21 |
| Griseofulvin Compound And Pharmaceutical Use Thereof App 20200216433 - Saito; Keiji ; et al. | 2020-07-09 |
| Peptides Inhibiting Klk1, Klk4, Or Klk4 And Klk8 App 20200207837 - Nishimiya; Daisuke ; et al. | 2020-07-02 |
| Peptide Library And Use Thereof App 20200199179 - Nishimiya; Daisuke ; et al. | 2020-06-25 |
| Pyrimidine Derivative App 20200172494 - Takeda; Yasuyuki ; et al. | 2020-06-04 |
| Anti-cdh6 Antibody And Anti-cdh6 Antibody-drug Conjugate App 20200171163 - SAITO; Atsuko ; et al. | 2020-06-04 |
| ENA ANTISENSE OLIGONUCLEOTIDE FOR INHIBITION OF alpha-SYNUCLEIN EXPRESSION App 20200172903A1 - | 2020-06-04 |
| Method For Producing A Spirooxindole Derivative App 20200172548 - YAMAUCHI; Motoshi ; et al. | 2020-06-04 |
| Method For Selecting Individuals To Be Administered Immune Checkpoint Inhibitor App 20200173999A1 - | 2020-06-04 |
| Griseofulvin compound Grant 10,654,821 - Saito , et al. | 2020-05-19 |
| Antibody for treating autoimmune diseases Grant 10,647,769 - Mukasa , et al. | 2020-05-12 |
| Nucleic Acid Biomarker And Use Thereof App 20200140954 - SCHNEIDER; Matthias ; et al. | 2020-05-07 |
| Thrombospondin 1-binding Peptide App 20200131230 - YAMAGUCHI; Takahiro ; et al. | 2020-04-30 |
| Methods for producing optically active valeric acid derivatives Grant 10,633,346 - Hayashi , et al. | 2020-04-28 |
| Antibody For Treating Autoimmune Diseases App 20200123253 - Mukasa; Ryuta ; et al. | 2020-04-23 |
| Tablet App 20200113842 - SEKINE; Kazuhisa | 2020-04-16 |
| Pediatric Osteoporosis Drug That Does Not Cause Growth Disorder App 20200115446A1 - | 2020-04-16 |
| Protein Biomarker And Uses Thereof App 20200115467 - SCHNEIDER; Matthias ; et al. | 2020-04-16 |
| Solid preparation including colorant Grant 10,603,285 - Tajiri , et al. | 2020-03-31 |
| Monoclonal Antibodies To Human Fibroblast Growth Factor Receptor 2 (hfgfr2) And Methods Of Use Thereof App 20200085946 - YOSHIMURA; Chigusa ; et al. | 2020-03-19 |
| Sulfonamide Compounds App 20200087321 - Miyazaki; Shojiro ; et al. | 2020-03-19 |
| Therapeutic Drug For Alport's Syndrome App 20200080080 - IIJIMA; Kazumoto ; et al. | 2020-03-12 |
| Cationic Lipid App 20200080086 - KOIZUMI; Makoto ; et al. | 2020-03-12 |
| Method For Treating Egfr-tki-resistant Non-small Cell Lung Cancer By Administration Of Anti-her3 Antibody-drug Conjugate App 20200061031 - YONESAKA; Kimio ; et al. | 2020-02-27 |
| Method for Producing 3, 6-Disubstituted Imidazo[1, 2-b]Pyridazine Derivative App 20200062765 - KOIKE; Ryoji ; et al. | 2020-02-27 |
| Griseofulvin compound Grant 10,570,109 - Saito , et al. Feb | 2020-02-25 |
| Solid preparation including antioxidant Grant 10,561,628 - Tajiri , et al. Feb | 2020-02-18 |
| N-phosphonoxymethl Prodrugs Of Hydroxyalkyl Thiadiazole Derivatives App 20200040019 - Khera; Manoj Kumar ; et al. | 2020-02-06 |
| Pyridine Compound App 20200039974 - Inagaki; Hiroaki ; et al. | 2020-02-06 |
| Peptide library and use thereof Grant 10,550,154 - Nishimiya , et al. Fe | 2020-02-04 |
| Anti-garp antibody Grant 10,550,198 - Satoh , et al. Fe | 2020-02-04 |
| Therapeutic Agent For Short Stature App 20200030414 - Morozumi; Naomi ; et al. | 2020-01-30 |
| Anti-gpr20 Antibody App 20200017583 - IIDA; Kenji ; et al. | 2020-01-16 |
| Urea Derivative App 20200017439 - Soneda; Tsuyoshi ; et al. | 2020-01-16 |
| Cationic lipid Grant 10,533,176 - Koizumi , et al. Ja | 2020-01-14 |
| Formulations Of A Compound Modulating Kinases App 20200010465 - Ibrahim; Prabha N. ; et al. | 2020-01-09 |
| Pyridone Derivatives Having Tetrahydropyranylmethyl Groups App 20200010458 - HAGINOYA; Noriyasu ; et al. | 2020-01-09 |
| Griseofulvin Compound App 20200002302 - Saito; Keiji ; et al. | 2020-01-02 |
| Anti-alk2 Antibody App 20200002427 - KATAGIRI; TAKENOBU ; et al. | 2020-01-02 |
| Combination of TAFIa inhibitor with plasminogen activator Grant 10,517,850 - Noguchi , et al. Dec | 2019-12-31 |
| Method For Predicting Sensitivity Of Cancer To Treatment With Pd-1 Immune Checkpoint Inhibitor App 20190376146A1 - | 2019-12-12 |
| Amide Derivative App 20190365688A1 - | 2019-12-05 |
| Anti-gprc5d Antibody And Molecule Containing Same App 20190367612A1 - | 2019-12-05 |
| Anti-cd3 Antibody And Molecules Comprising The Antibody App 20190359712A1 - | 2019-11-28 |
| Treatment method by combined use of MDM2 inhibitor and BTK inhibitor Grant 10,485,794 - Seki Nov | 2019-11-26 |
| Monoclonal antibodies to human fibroblast growth factor receptor 2 (HFGFR2) and methods of use thereof Grant 10478496 - | 2019-11-19 |
| Pharmaceutical Composition Used For Treatment Of Htlv-1-associated Myelopathy App 20190343816A1 - | 2019-11-14 |
| Dna Element Having The Activity Of Enhancing Foreign Gene Expression App 20190345515A1 - | 2019-11-14 |
| Synthesis Of A Compound That Modulates Kinases App 20190337943A1 - | 2019-11-07 |
| Formulations Of A Compound Modulating Kinases App 20190337944A1 - | 2019-11-07 |
| Therapy For Drug-resistant Cancer By Administration Of Anti-her2 Antibody/drug Conjugate App 20190330368A1 - | 2019-10-31 |
| Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 Grant RE47,672 - Sooknanan , et al. Oc | 2019-10-29 |
| Anti-Orai1 Antibody App 20190322740A1 - | 2019-10-24 |
| Combination Of Antibody-drug Conjugate And Immune Checkpoint Inhibitor App 20190314362A1 - | 2019-10-17 |
| Pyridone derivatives having tetrahydropyranylmethyl groups Grant 10,442,797 - Haginoya , et al. Oc | 2019-10-15 |
| Novel Endo-beta-n-acetylglucosaminidase App 20190309028A1 - | 2019-10-10 |
| Agent for treating and/or preventing adult T cell leukemia/lymphoma Grant 10,434,091 - Watanabe , et al. O | 2019-10-08 |
| Formulations of a compound modulating kinases Grant 10,435,404 - Ibrahim , et al. O | 2019-10-08 |
| Composition Containing Anti-robo4 Antibody And Other Agents App 20190300607A1 - | 2019-10-03 |
| Anti-ALK2 antibody Grant 10,428,148 - Katagiri , et al. October 1, 2 | 2019-10-01 |
| Sulfonamide Derivative Having Coumarin Skeleton App 20190284198A1 - | 2019-09-19 |
| DNA element having the activity of enhancing foreign gene expression Grant 10,407,694 - Nishimiya , et al. Sept | 2019-09-10 |
| Synthesis of a compound that modulates kinases Grant 10,399,975 - Ibrahim , et al. Sep | 2019-09-03 |
| Hydroxyalkyl thiadiazole derivatives Grant 10,399,968 - Khera , et al. Sep | 2019-09-03 |
| Anti-HER3 antibody-drug conjugate Grant 10,383,878 - Hettmann , et al. A | 2019-08-20 |
| Treatment Method by Combined Use of MDM2 Inhibitor and DNA Methyltransferase Inhibitor App 20190240210A1 - | 2019-08-08 |
| Promoter of Hspa5 Gene App 20190241907A1 - | 2019-08-08 |
| Sustained-release Pharmaceutical Composition For Treatment And Prevention Of Eye Disease App 20190233466A1 - | 2019-08-01 |
| Anti-gpr20 Antibody And Anti-gpr20 Antibody-drug Conjugate App 20190225686A1 - | 2019-07-25 |
| Crystals Of [2-(1-methyl-1h-pyrazol-4-yl)-6(morpholin-4-yl)-9h-purin-8-yl][4-(morpholin-4-yl)piperidin-1-yl]methanone And Pharmaceutically Acceptable Salt Thereof App 20190225614A1 - | 2019-07-25 |
| Human anti-FGFR4 antibody Grant 10,358,498 - Abraham , et al. | 2019-07-23 |
| Anti-Orai1 antibody Grant 10,351,624 - Komai , et al. July 16, 2 | 2019-07-16 |
| Method for removing dimethoxybenzyl group Grant 10,316,026 - Kadota , et al. | 2019-06-11 |
| Method for producing pyrrole derivative, and intermediate thereof Grant 10,308,604 - Watanabe , et al. | 2019-06-04 |
| Method for producing 1-(acyloxy)alkyl carbamate derivative Grant 10,308,612 - Ueda , et al. | 2019-06-04 |
| Antibody targeting osteoclast-related protein Siglec-15 Grant 10,308,715 - Hiruma , et al. | 2019-06-04 |
| Measurement method for thrombin production Grant 10,266,871 - Morishima , et al. | 2019-04-23 |
| Terpenoid derivatives Grant 10,253,060 - Komoriya , et al. | 2019-04-09 |
| Anti-TROP2 antibody-drug conjugate Grant 10,227,417 - Agatsuma , et al. | 2019-03-12 |
| Pyridine compounds Grant 10,221,195 - Miyazaki , et al. | 2019-03-05 |
| Sustained-release pharmaceutical composition for treatment and prevention of eye disease Grant 10,208,082 - Kasuya , et al. Feb | 2019-02-19 |
| Complex containing oligonucleotide having immunopotentiating activity and use thereof Grant 10,202,606 - Ishii , et al. Feb | 2019-02-12 |
| Antibody-drug conjugate Grant 10,195,288 - Masuda , et al. Fe | 2019-02-05 |
| Method for producing dicarboxylic acid compound Grant 10,189,804 - Murakami , et al. Ja | 2019-01-29 |
Company Registrations
| SEC | 0001446393 | Daiichi Sankyo Co Ltd of JAPAN |
| SEC | 0001340156 | Daiichi Sankyo Company, LTD of JAPAN |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 